recombinant interferon alpha 2b-like protein

01/01/2021 - "In conclusion, the combination of LPV/r and Novaferon may have better efficacy against COVID-19. "
10/01/2020 - "SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial."
01/01/2021 - "Novaferon, treatment in COVID-19 patients."
01/01/2021 - "Reply to "Novaferon, treatment in COVID-19 patients"."
10/01/2020 - "Novaferon exhibited anti-SARS-CoV-2 effects in vitro and in COVID-19 patients. "

05/01/2015 - "Novaferon can improve the DAI scores and colonic tissue injury in ulcerative colitis induced by DSS in mice, and down-regulate the TNF-α expression in dose-dependent manner."
05/01/2015 - "To explore the effects of novaferon on dextran sulfate sodium (DSS)-induced colitis and expression of TNF-α in mice and to evaluate the efficacy of novaferon on ulcerative colitis and the possible mechanisms. "

05/01/2015 - "[Novaferon ameliorates dextran sulfate sodium-induced colitis and downregulates expression of TNF-α in mice]."
05/01/2015 - "To explore the effects of novaferon on dextran sulfate sodium (DSS)-induced colitis and expression of TNF-α in mice and to evaluate the efficacy of novaferon on ulcerative colitis and the possible mechanisms. "

01/01/2013 - "To study the role of Novaferon on TNF-α production and expression of NF-κB mRNA in monocytes isolated from normal human peripheral blood and to provide theoretical basis for treatment of immunological diseases with Novaferon. "

06/01/2015 - "Novaferon showed moderate efficacy and was well-tolerated in patients with metastatic colorectal cancer (mCRC), especially with the 20 μg injected 3 times a week strategy.Although"
06/01/2015 - "To observe the efficacy, safety, and optimal dosage of recombinant antitumor and antivirus protein (Novaferon) in treating patients with metastatic colorectal cancer (mCRC) who failed at least two prior palliative regimens. "